journal article·2024-06Open access

Tumor Biomechanics Alters Metastatic Dissemination of Triple Negative Breast Cancer via Rewiring Fatty Acid Metabolism

Elysse C. Filipe, Sipiththa Velayuthar, Ashleigh Philp, Max Nobis, Sharissa L. Latham, Amelia L. Parker, Kendelle J. Murphy, Kaitlin Wyllie, Gretel S. Major, Osvaldo Contreras, Ellie T. Y. Mok, Ronaldo F. Enriquez, Suzanne McGowan, Kristen Feher, Lake‐Ee Quek, Sarah E. Hancock, Michelle Yam, Emmi Tran, Yordanos F. I. Setargew, Joanna N. Skhinas, Jessica L. Chitty, Monica Phimmachanh, Jeremy Z. R. Han, Antonia L. Cadell, Michael Papanicolaou, Hadi Mahmodi, Beata Kiedik, Simon Junankar, Samuel E. Ross, Natasha Lam, Rhiannon Coulson, Jessica Yang, Anaiis Zaratzian, Andrew M. Da Silva, Michael Tayao, Ian L. Chin, Aurélie Cazet, Maya Kansara, Davendra Segara, Andrew Parker, Andrew J. Hoy, Richard P. Harvey, Ozren Bogdanovic, Paul Timpson, David R. Croucher, Elgene Lim, Alexander Swarbrick, Jeff Holst, Nigel Turner, Yu Suk Choi, Irina V. Kabakova, Andrew Philp, Thomas R. Cox

Advanced Science· Volume 11· Issue 23

Abstract

Abstract In recent decades, the role of tumor biomechanics on cancer cell behavior at the primary site has been increasingly appreciated. However, the effect of primary tumor biomechanics on the latter stages of the metastatic cascade, such as metastatic seeding of secondary sites and outgrowth remains underappreciated. This work sought to address this in the context of triple negative breast cancer (TNBC), a cancer type known to aggressively disseminate at all stages of disease progression. Using mechanically tuneable model systems, mimicking the range of stiffness's typically found within breast tumors, it is found that, contrary to expectations, cancer cells exposed to softer microenvironments are more able to colonize secondary tissues. It is shown that heightened cell survival is driven by enhanced metabolism of fatty acids within TNBC cells exposed to softer microenvironments. It is demonstrated that uncoupling cellular mechanosensing through integrin β1 blocking antibody effectively causes stiff primed TNBC cells to behave like their soft counterparts, both in vitro and in vivo. This work is the first to show that softer tumor microenvironments may be contributing to changes in disease outcome by imprinting on TNBC cells a greater metabolic flexibility and conferring discrete cell survival advantages.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cellular Mechanics and Interactions · Caveolin-1 and cellular processes · Cancer Cells and Metastasis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Cancer Ecosystems Program Garvan Institute of Medical Research and The Kinghorn Cancer Centre Darlinghurst NSW 2010 Australia

School of Clinical Medicine St Vincent's Clinical Campus UNSW Medicine & Health UNSW Sydney Sydney 2010 Australia

Centenary Institute Camperdown NSW 2050 Australia

Victor Chang Cardiac Research Institute Darlinghurst NSW 2010 Australia

South Australian immunoGENomics Cancer Institute (SAiGENCI) Adelaide SA 5005 Australia

School of Mathematics and Statistics, Charles Perkins Centre University of Sydney Sydney 2050 Australia

School of Biomedical Sciences UNSW Sydney Sydney 2033 Australia

School of Life Sciences University of Technology Sydney Sydney NSW 2007 Australia

School of Mathematical and Physical Sciences University of Technology Sydney Sydney NSW 2007 Australia

School of Human Sciences University of Western Australia Crawley WA 6009 Australia

St Vincent's Hospital Darlinghurst NSW 2010 Australia

Department of Pathology St. Vincent's Hospital Sydney 2010 Australia

School of Medical Sciences Charles Perkins Centre Faculty of Medicine and Health University of Sydney Sydney NSW 2050 Australia

School of Biotechnology and Biomolecular Sciences UNSW Sydney Sydney 2033 Australia

Biology of Ageing Laboratory and Centre for Healthy Ageing Centenary Institute Missenden Road, Camperdown Sydney NSW 2050 Australia

School of Sport Exercise and Rehabilitation Sciences University of Technology Sydney Ultimo NSW 2007 Australia

Funding

Australian Research Council · Perpetual · National Heart Foundation of Australia · Cancer Council NSW · National Health and Medical Research Council

References (100+)

Show source-provided references
1. 10.1038/s41568-020-00329-710.1038/s41568-020-00329-7 ↗
2. 10.1038/nrc254410.1038/nrc2544 ↗
3. 10.1158/0008-5472.CAN-22-041910.1158/0008-5472.CAN-22-0419 ↗
4. 10.1016/j.cell.2009.10.02710.1016/j.cell.2009.10.027 ↗
5. 10.1371/journal.pone.010093710.1371/journal.pone.0100937 ↗
6. 10.1016/j.ccr.2005.08.01010.1016/j.ccr.2005.08.010 ↗
7. 10.1038/s41556-023-01092-110.1038/s41556-023-01092-1 ↗
8. 10.1038/ncb315710.1038/ncb3157 ↗
9. 10.1038/oncsis.2017.5410.1038/oncsis.2017.54 ↗
10. 10.1096/fj.13-24561310.1096/fj.13-245613 ↗
11. 10.1073/pnas.111807310910.1073/pnas.1118073109 ↗
12. 10.1073/pnas.161133811310.1073/pnas.1611338113 ↗
13. 10.1126/science.aaw547310.1126/science.aaw5473 ↗
14. 10.1038/s41568-020-00320-210.1038/s41568-020-00320-2 ↗
15. 10.1038/s41568-021-00378-610.1038/s41568-021-00378-6 ↗
16. 10.1016/j.cell.2016.12.03910.1016/j.cell.2016.12.039 ↗
17. 10.1186/s40170-017-0168-x10.1186/s40170-017-0168-x ↗
18. 10.1186/bcr347210.1186/bcr3472 ↗
19. 10.1007/s13277-013-0707-110.1007/s13277-013-0707-1 ↗
20. 10.1016/j.cmet.2020.10.01210.1016/j.cmet.2020.10.012 ↗
21. 10.1186/s13058-014-0434-610.1186/s13058-014-0434-6 ↗
22. 10.1016/j.cmet.2019.08.01310.1016/j.cmet.2019.08.013 ↗
23. 10.1016/j.cmet.2021.12.00110.1016/j.cmet.2021.12.001 ↗
24. 10.1038/ncb303910.1038/ncb3039 ↗
25. 10.1073/pnas.220545611910.1073/pnas.2205456119 ↗
26. 10.1016/j.tcb.2018.04.00210.1016/j.tcb.2018.04.002 ↗
27. 10.1038/nrc348310.1038/nrc3483 ↗
28. 10.1038/s41416-019-0650-z10.1038/s41416-019-0650-z ↗
29. 10.1016/j.neo.2015.08.00510.1016/j.neo.2015.08.005 ↗
30. 10.1038/srep0551210.1038/srep05512 ↗
31. 10.1007/s00330-013-2866-210.1007/s00330-013-2866-2 ↗
32. 10.3892/ol.2017.638510.3892/ol.2017.6385 ↗
33. 10.1038/nnano.2012.16710.1038/nnano.2012.167 ↗
34. 10.1158/2159-8290.CD-16-073310.1158/2159-8290.CD-16-0733 ↗
35. 10.1002/jso.2170910.1002/jso.21709 ↗
36. 10.1038/s41592-023-02054-z10.1038/s41592-023-02054-z ↗
37. 10.1038/s41592-018-0076-110.1038/s41592-018-0076-1 ↗
38. 10.1088/2515-7647/abbf8c10.1088/2515-7647/abbf8c ↗
39. 10.1007/978-1-4939-2809-5_1810.1007/978-1-4939-2809-5_18 ↗
40. 10.1038/nm.384110.1038/nm.3841 ↗
41. 10.1038/s41467-022-34041-x10.1038/s41467-022-34041-x ↗
42. 10.1091/mbc.E18-05-031910.1091/mbc.E18-05-0319 ↗
43. 10.1038/nnano.2007.38810.1038/nnano.2007.388 ↗
44. 10.1038/s43586-021-00062-x10.1038/s43586-021-00062-x ↗
45. 10.1038/nmeth.328110.1038/nmeth.3281 ↗
46. 10.1016/j.devcel.2018.02.01510.1016/j.devcel.2018.02.015 ↗
47. 10.1038/s41568-019-0221-x10.1038/s41568-019-0221-x ↗
48. 10.1158/0008-5472.CAN-12-223310.1158/0008-5472.CAN-12-2233 ↗
49. 10.1039/c2ib00149g10.1039/c2ib00149g ↗
50. 10.1038/nmat388910.1038/nmat3889 ↗
51. 10.1038/nmat478010.1038/nmat4780 ↗
52. 10.1016/j.biomaterials.2017.09.01210.1016/j.biomaterials.2017.09.012 ↗
53. 10.1091/mbc.E22-10-046910.1091/mbc.E22-10-0469 ↗
54. 10.3390/s12091234710.3390/s120912347 ↗
55. 10.1016/j.cmet.2021.04.01710.1016/j.cmet.2021.04.017 ↗
56. 10.1038/ncb353710.1038/ncb3537 ↗
57. 10.1016/j.actbio.2021.07.00910.1016/j.actbio.2021.07.009 ↗
58. 10.1038/s41586-020-1998-110.1038/s41586-020-1998-1 ↗
59. 10.1038/s41556-022-00843-w10.1038/s41556-022-00843-w ↗
60. 10.1038/s41556-018-0270-510.1038/s41556-018-0270-5 ↗
61. 10.1038/s41467-019-09152-710.1038/s41467-019-09152-7 ↗
62. 10.1016/j.cell.2011.02.01310.1016/j.cell.2011.02.013 ↗
63. 10.1038/s41586-022-04758-210.1038/s41586-022-04758-2 ↗
64. 10.1038/s41556-022-00881-410.1038/s41556-022-00881-4 ↗
65. 10.1016/j.cmet.2017.09.00610.1016/j.cmet.2017.09.006 ↗
66. 10.1016/j.celrep.2021.10875010.1016/j.celrep.2021.108750 ↗
67. 10.1016/j.ab.2017.07.00910.1016/j.ab.2017.07.009 ↗
68. 10.1096/fj.202001693R10.1096/fj.202001693R ↗
69. 10.1038/s41598-019-55296-310.1038/s41598-019-55296-3 ↗
70. 10.1016/0076-6879(95)60154-610.1016/0076-6879(95)60154-6 ↗
71. 10.1002/cyto.a.2106110.1002/cyto.a.21061 ↗
72. 10.1038/cddis.2012.17110.1038/cddis.2012.171 ↗
73. 10.1007/978-1-4939-9027-6_1810.1007/978-1-4939-9027-6_18 ↗
74. 10.1074/jbc.M116.77447110.1074/jbc.M116.774471 ↗
75. 10.1038/nature0826810.1038/nature08268 ↗
76. 10.1038/s41556-018-0034-210.1038/s41556-018-0034-2 ↗
77. 10.1016/j.ccell.2018.02.00110.1016/j.ccell.2018.02.001 ↗
78. 10.1038/nature1106610.1038/nature11066 ↗
79. 10.1016/j.celrep.2016.02.00410.1016/j.celrep.2016.02.004 ↗
80. 10.1038/s41467-023-42748-810.1038/s41467-023-42748-8 ↗
81. 10.1038/s41467-019-10592-410.1038/s41467-019-10592-4 ↗
82. 10.1016/j.cmet.2018.09.01210.1016/j.cmet.2018.09.012 ↗
83. 10.1016/j.cmet.2021.05.00910.1016/j.cmet.2021.05.009 ↗
84. 10.1016/j.ebiom.2016.10.01210.1016/j.ebiom.2016.10.012 ↗
85. 10.1007/s00432-019-02847-w10.1007/s00432-019-02847-w ↗
86. 10.1007/s10585-021-10102-110.1007/s10585-021-10102-1 ↗
87. 10.1038/s41556-020-0477-010.1038/s41556-020-0477-0 ↗
88. 10.1016/j.bpj.2021.02.04410.1016/j.bpj.2021.02.044 ↗
89. 10.1016/S0092-8674(02)00971-610.1016/S0092-8674(02)00971-6 ↗
90. 10.1038/nrclinonc.2016.6010.1038/nrclinonc.2016.60 ↗
91. 10.1038/s41388-022-02258-110.1038/s41388-022-02258-1 ↗
92. 10.1186/1741-7015-6-1110.1186/1741-7015-6-11 ↗
93. 10.1083/jcb.20030501010.1083/jcb.200305010 ↗
94. 10.1038/s41556-020-0523-y10.1038/s41556-020-0523-y ↗
95. 10.1038/s41556-018-0131-210.1038/s41556-018-0131-2 ↗
96. 10.15252/embr.20143924610.15252/embr.201439246 ↗
97. 10.15252/embj.20169491210.15252/embj.201694912 ↗
98. 10.1073/pnas.210536711810.1073/pnas.2105367118 ↗
99. 10.1186/1476-4598-9-3510.1186/1476-4598-9-35 ↗
100. 10.1002/hep.2410810.1002/hep.24108 ↗